« Michael Reagan: Legalized Murder Looms in Florida | Main | Please Email Amnesty International On Behalf Of Terri Schindler-Schiavo »
February 28, 2005
Multiple Sclerosis Drug Tysabri Pulled Off Market
Topics: Clinical PharmacologyBiogen Idec and Elan announced Monday they have voluntarily withdrawn Tysabri, a drug used to treat multiple sclerosis, after one patient died and another developed a serious disease of the central nervous system after taking it in combination with Avonex for more than two years.
Hat tip - Corante, with more commentary.
Posted by Hyscience at February 28, 2005 1:50 PM
Articles Related to Clinical Pharmacology:
- Britain tests first Cannabis related medicine for rheumatoid arthritis - Nov 13, 2005
- Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma - May 26, 2005
- Cystatin C May Push Creatinine Off Risk Radar - May 19, 2005
- Cancer Treatment Success Stuns Scientists - May 16, 2005
- Antibody, cancer drug combo shows promise against breast tumors - May 16, 2005
- USC researchers determine mechanism of action of motexafin gadolinium (Xcytrin) - May 02, 2005
- Herceptin® Combined With Chemotherapy Improves Disease-Free Survival for Patients With Early-Stage Breast Cancer - Apr 26, 2005
- Selenium will have critical role in prostate cancer treatment - Fox Chase Cancer Center - Apr 21, 2005
- Traditional Medicine Derivatives Kill Cancer Cells - Apr 20, 2005
- Compound from Chinese medicine shows promise in head and neck cancer, U-M study finds - Apr 19, 2005
Comments
Hat tip to you for your previous post in January where you suggested that Tysabri should have been in clinical trials longer.
Posted by: Zack (Brain Waves) at February 28, 2005 3:37 PM
;
